Price $19.02 |
Market Cap
100M
|
Sector Health Care |
Div. Growth
10.00%
|
|
P/E
14.4
|
P/B
5.59
|
P/S
2.44
|
Dividend %
3.80%
|
|
P/CF
249.4
|
P/FCF
123.6
|
Op. Cash Flow
6K
|
FCF
0.1
|
|
Op. Margin
18.90%
|
Net Margin
14.20%
|
ROE
32.50%
|
ROI
33.20%
|
|
ROA
22.50%
|
EPS Growth
-1.80%
|
Current Ratio
3.3
|
Debt/Equity
12.90%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| China Pharma Holdings, Inc. (CPHI) | $0.27 | - | - | 12.7M | Strong Buy |
| PDL BioPharma Inc (PDLI) | $3.33 | - | - | 464.2M | Strong Buy |
| Biostem Technologies Inc (BSEM) | $2.87 | - | - | 26M | Strong Buy |
| BioScrip Inc (BIOS) | $3.61 | - | - | 464.8M | Strong Buy |
| Medical Transcription Billing (MTBC) | $4.68 | - | - | 48.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
